- Home
- RHI vs LNTH Comparison
RHI vs LNTH Comparison
Compare RHI & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHI
- LNTH
- Stock Information
- Founded
- RHI 1948
- LNTH 1956
- Country
- RHI United States
- LNTH United States
- Employees
- RHI N/A
- LNTH N/A
- Industry
- RHI Professional Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RHI Consumer Discretionary
- LNTH Health Care
- Exchange
- RHI Nasdaq
- LNTH Nasdaq
- Market Cap
- RHI 3.7B
- LNTH 3.6B
- IPO Year
- RHI N/A
- LNTH 2015
- Fundamental
- Price
- RHI $34.99
- LNTH $51.74
- Analyst Decision
- RHI Hold
- LNTH Strong Buy
- Analyst Count
- RHI 5
- LNTH 6
- Target Price
- RHI $49.80
- LNTH $89.67
- AVG Volume (30 Days)
- RHI 1.5M
- LNTH 1.5M
- Earning Date
- RHI 10-21-2025
- LNTH 11-05-2025
- Dividend Yield
- RHI 6.66%
- LNTH N/A
- EPS Growth
- RHI N/A
- LNTH N/A
- EPS
- RHI 1.75
- LNTH 3.77
- Revenue
- RHI $5,569,026,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- RHI N/A
- LNTH N/A
- Revenue Next Year
- RHI $3.32
- LNTH $3.24
- P/E Ratio
- RHI $20.21
- LNTH $13.74
- Revenue Growth
- RHI N/A
- LNTH 5.75
- 52 Week Low
- RHI $33.18
- LNTH $47.25
- 52 Week High
- RHI $78.41
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- RHI 39.99
- LNTH 36.67
- Support Level
- RHI $34.71
- LNTH $51.94
- Resistance Level
- RHI $36.70
- LNTH $55.24
- Average True Range (ATR)
- RHI 1.10
- LNTH 1.86
- MACD
- RHI -0.07
- LNTH 0.36
- Stochastic Oscillator
- RHI 8.14
- LNTH 2.06
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.